Paclitaxel liposome and preparation method therefor

A liposome and paclitaxel technology, applied in the field of medicine, can solve problems such as side effects and water insolubility of paclitaxel, and achieve the effects of reducing toxic side effects, enhancing anti-tumor effect and improving targeting.

Inactive Publication Date: 2007-08-15
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The purpose of the present invention is to solve the water insolubility and side effects of paclitaxel and prepare thermosensitive liposomes, long-circulation liposomes and thermosensitive long-circulation liposomes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] prescription:

[0029] Paclitaxel 0.4g

[0030] Soybean Lecithin for Injection 20.0g

[0031] Cholesterol 2.4g

[0032] Excipient D 5.0g

[0033] Octadecylamine 0.1g

[0034] Vitamin E 0.2g

[0035] Buffered saline solution to 200mL

[0036] Preparation Process:

[0037]Dissolve the prescribed amount of paclitaxel, soybean lecithin for injection, cholesterol, excipient D, and vitamin E in an organic solvent and pour it into a pear-shaped bottle, then add a small amount of buffered saline solution containing octadecylamine, ultrasonically make it into a uniform milk, and use a rotary evaporator The organic solvent was removed under reduced pressure to form a gel, vortexed and distilled under reduced pressure at intervals to obtain a white uniform liposome solution, and then the volume was adjusted to 200 mL with buffer solution. Then pass through the membrane (0.22 μm) under pressure to depyrogenize the entire particle, then pack into vials and freeze-dry to obtai...

Embodiment 2

[0039] prescription:

[0040] Paclitaxel 0.4g

[0041] Soybean Lecithin for Injection 20.0g

[0042] Cholesterol 2.4g

[0043] Excipient D 5.0g

[0044] Octadecylamine 0.1g

[0045] Vitamin E 0.2g

[0046] Buffered saline solution to 200mL

[0047] Preparation Process:

[0048] Dissolve the prescribed amount of paclitaxel, soybean lecithin for injection, cholesterol, excipient D, and vitamin E in an organic solvent and pour it into a pear-shaped bottle, then add a small amount of buffered saline solution containing octadecylamine, ultrasonically make it into a uniform milk, and use a rotary evaporator The organic solvent was removed under reduced pressure to form a gel, vortexed and distilled under reduced pressure at intervals to obtain a white uniform liposome solution, and then the volume was adjusted to 200 mL with buffer solution. Then pass through the membrane (0.22 μm) under pressure to depyrogenize the whole grain, pack into ampoules, freeze in the refrigerator ...

Embodiment 3

[0050] prescription:

[0051] Paclitaxel 0.4g

[0052] Soybean Lecithin for Injection 20.0g

[0053] Cholesterol 2.4g

[0054] Excipient D 5.0g

[0055] Sucrose 5.0g

[0056] Mannitol 0.1g

[0057] Octadecylamine 0.1g

[0058] Vitamin E 0.2g

[0059] Buffered saline solution to 200mL

[0060] Preparation Process:

[0061] Dissolve the prescribed amount of paclitaxel, soybean lecithin for injection, cholesterol, excipient D, and vitamin E in an organic solvent and pour it into a pear-shaped bottle. Rotate and evaporate the organic solvent at 30 rpm and 60°C in a water bath to make the glass bottle Form a dry film on the wall, dissolve the prescribed amount of sucrose and mannitol in 200mL of buffered saline solution, pour it into a pear-shaped bottle and rotate it at 40 rpm at room temperature (25°C) to hydrate until the dry film on the wall of the bottle is completely removed. The resulting coarse suspension was hydrated at room temperature (25° C.) for 1 hour until t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a Paclitaxel liposome and process for preparation, wherein the components include Paclitaxel 1-30%, phosphatides 1-95%, cholesterin 0-30%, thermo-sensible auxiliary material D 0-50%, auxiliary material G 0-50%, freeze-drying protecting agent 0-80%, octadecyl amine 0-10%, anti-oxidant 0.001-50% and right amount of buffer salt.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to thermosensitive liposomes, long-circulation liposomes and thermosensitive long-circulation liposome preparations of the antitumor drug paclitaxel, and also relates to preparation methods of these liposomes. Background technique [0002] Paclitaxel is a monomeric compound with definite and strong anti-cancer effects discovered by humans in the late 20th century. Oncology has become the drug of choice. [0003] At present, paclitaxel injection in clinical application includes domestic paclitaxel  , Taxol  , import Taxol  (USA BMS company), Anzatax  (Australian Fauliding company) and other products, these products all utilize surfactant solubilization method to solve the shortcoming that paclitaxel is insoluble in water, to reach the purpose of intravenous administration. However, these preparations have many side effects in clinical use, especially the existing commercially...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/127A61K31/337A61P35/00
Inventor 邓英杰王浩
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap